Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

Política de privacidad

Inicio Explorar nav.journalClub Tendencias

⌘+K

January 1, 1972Open Access

Use of Pyocin 78-C2 in the Treatment of Pseudomonas aeruginosa Infection in Mice

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Purified pyocin, administered parenterally to mice infected with sensitive strains of Pseudomonas aeruginosa, afforded significant protection against two of the three strains studied.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Merrikin et al. (Sat,) studied this question.

synapsesocial.com/papers/6a2f9711e1b0e7f293a46038 https://doi.org/https://doi.org/10.1128/am.23.1.164-165.1972

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Individual Comparisons of Grouped Data by Ranking Methods1946 · 494 citations
2In Vitro and In Vivo Characterization of Pyocin1967 · 90 citations
3On the purification and some properties of a pyocin, a bacteriocin produced by Pseudomonas aeruginosa1962 · 55 citations
4ON THE BIOSYNTHESIS OF PYOCYANINE1959 · 108 citations
5Über das grüne Stoffwechselprodukt des Bacillus Chlororaphis1930 · 38 citations

Use of Pyocin 78-C2 in the Treatment of Pseudomonas aeruginosa Infection in Mice | Synapse